Species Identification and Antimicrobial Susceptibility of Mycobacterial Isolates from Dogs and Cats
Abstract
Nontuberculous Mycobacterium (NTM) species are increasingly recognized as opportunistic pathogens in companion animals, yet data on species distribution and antimicrobial resistance remain limited. The goal of this study was to evaluate species identification methods and to determine the antimicrobial susceptibility profiles of NTM isolates obtained from cat and dog samples submitted to the University of Tennessee Veterinary Diagnostic Laboratory. Twenty-nine NTM isolates (25 feline, 4 canine) collected between 2016 and 2022 were cultured and identified using MALDI-TOF MS and 16S rRNA sequencing. Antimicrobial susceptibility testing (AST) was performed by broth microdilution. MALDI‑TOF MS identified 25 isolates to the species level. The isolates were classified into four rapidly growing mycobacterial groups: 12 isolates within the Mycobacterium fortuitum complex, 10 isolates within the M. smegmatis group, 4 isolates within the M. abscessus group, and 1 isolate within the M. mucogenicum group. Four isolates, including two slow‑growing strains, were not identified by MALDI‑TOF MS but were identified and grouped based on 16S rRNA sequencing. There was limited agreement in species‑level identification between the two primer sets used. AST revealed consistent susceptibility to amikacin and moxifloxacin, while resistance was highest to doxycycline (41%), clarithromycin (37%), and tobramycin (33%). Rapidly growing NTM predominates in feline cutaneous infections, with…
How strong is the evidence?
Evidence Hub reads this as a preprint, done in animal, not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.